Okla. high court reverses $465M opioid ruling

OKLAHOMA CITY — The Oklahoma Supreme Court on Tuesday overturned a $465 million opioid ruling against drugmaker Johnson & Johnson, finding that a lower court wrongly interpreted the state’s public nuisance law.

The ruling was the second blow this month to a government case that used a similar approach to try to hold drugmakers responsible for national opioid abuse. Public nuisance claims are at the heart of some 3,000 lawsuits brought by state and local governments against drugmakers, distribution companies and pharmacies.

The court ruled in a 5-1 decision that

District Judge Thad Balkman in 2019 was wrong to find that New Jersey-based J&J and its Belgium-based subsidiary Janssen Pharmaceuticals violated the state’s public nuisance statute.

“The court has allowed public nuisance claims to address discrete, localized problems, not policy problems,” according to the opinion written by Justice James R. Winchester.

The high court said that although it wouldn’t want to downplay the suffering that thousands of Oklahomans have gone through because of opioids, the question was whether the company’s marketing and sale of opioids created a public nuisance.

“J&J no longer promotes any prescription opioids and has not done so for several years,” since 2015, Winchester wrote. “Even with J&J’s marketing practices these ... medications amounted to less than 1% of all Oklahoma opioid prescriptions.”

State statistics show that from 2007 to 2017, more than 4,600 people in Oklahoma died from overdoses from opioids, including prescription painkillers and illicit versions such as heroin and illegally made fentanyl. Nationally, opioids have been linked to more than 500,000 deaths since 2000.

The ruling comes a week after a California judge issued a tentative ruling that said local governments had not proven that Johnson & Johnson used deceptive marketing to inflate prescriptions of their painkillers, leading to a public nuisance.